Tata Chemicals posts FY24 consolidated income from operations at Rs. 15,421 Cr
General

Tata Chemicals posts FY24 consolidated income from operations at Rs. 15,421 Cr

During Q4FY24, the Group has recognised a non-cash write-down of assets with respect to UK (Lostock Plant), aggregating to Rs. 963 crore which has been disclosed as an exceptional loss

  • By ICN Bureau | April 30, 2024

Tata Chemicals Limited declared its financial results for the quarter and full year ended March 31, 2024. On a consolidated basis, for the full year, the income from operations stood at Rs. 15,421 crore as compared to Rs. 16,789 crore in FY2023. EBITDA stood at Rs. 2,847 crore as compared to Rs. 3,822 crore in FY2023. PAT (before exceptional items and Non-Controlling Interest (‘NCI’)) stood at Rs.1,310 crore as compared to Rs.2,452 crore in FY2023.

On a standalone basis, for the full year, the income stood at Rs. 4,384 crore as compared to Rs. 4,930 crore in FY2023. PAT stood at Rs.  794 crore (before exceptional items) as compared to Rs.  1,027 crore in FY2023.

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “Overall demand for soda ash in India stayed stable during the quarter on account of rising demand from the detergent and chemical sectors. During the year, salt production & sales were at the highest level. The European soda ash market remained under pressure due to muted demand and margin pressure leading to one-time non-cash charge of Rs. 963 Cr in UK. The Company’s overall sales volume grew sequentially from the previous quarter, despite adverse price movement on account of market factors. We continue to focus on customer engagement and sustainable performance, whilst maintaining a prudent balance sheet.

“Global demand is stable; however, market remains cautious due to ongoing geopolitical instabilities, pressure from Chinese real estate market, high interest rates and situation of oversupply. We expect sustainability trend will drive the demand for newer applications like solar glass and lithium which will fuel growth. Our focus is on timely execution of expansion projects and efficient cost management. We continue to work with our customers and other stakeholders on our sustainability and digitization efforts.”

Consolidated Highlights Q4FY24

● Consolidated Revenue from operations stood at Rs. 3,475 crore as compared to Rs.4,407 crore for corresponding quarter of last year

● Consolidated Profit After Tax (before exceptional items and NCI) from continuing operations was Rs.145 crore as compared to Rs. 694 crore for corresponding quarter of last year

● Revenue and EBITDA were impacted due to lower volumes of soda ash and pricing pressure across all regions

● Group has recognized, a non-cash write-down of assets aggregating to Rs. 963 crore in UK, which has been disclosed as an exceptional loss

● Consolidated gross debt stood at Rs. 5,563 crore lower by Rs. 733 crore as compared to corresponding quarter of last year and net debt stood at Rs. 4,163 crore higher by Rs. 265 crore as compared to corresponding quarter of last year

Standalone Highlights Q4FY24

● Standalone Revenue from operations stood at Rs. 1,090 crore as compared to Rs. 1,302 crore for corresponding quarter of last year

● Standalone Profit After Tax from continuing operations was Rs. 217 crore as compared to Rs. 213 crore for corresponding quarter of last year

● Highest salt production & sales were witnessed during the current quarter. However, Company witnessed lower soda ash volumes and prices and the future price trend is expected to be at same level

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization

Aim to become import substitute for instrumentation business in India
Aim to become import substitute for instrumentation business in India
Vinayak M. Patankar, Sreejith Kumar Whole Time Director & CEO, Borosil Scientific Ltd. , Associate Vice President - Design, Borosil Scientific Ltd.

Looking at increasing manufacturing base outside India
Looking at increasing manufacturing base outside India
Sidharth A. Choksi Executive Vice President, Hindustan Platinum Pvt. Ltd

Developing new products like Vitamin B1 and Vitamin B6
Developing new products like Vitamin B1 and Vitamin B6
Hemal Mehta, Sachin Mehta Chairman, Sudarshan Pharma Industries Ltd. & Managing Director, Sudarshan Pharma Industries Ltd.